349 related articles for article (PubMed ID: 14607899)
41. Back to the future--defining NK cells and T cells.
Lanier LL
Eur J Immunol; 2007 Jun; 37(6):1424-6. PubMed ID: 17523211
[TBL] [Abstract][Full Text] [Related]
42. TCR specificity dictates CD94/NKG2A expression by human CTL.
Jabri B; Selby JM; Negulescu H; Lee L; Roberts AI; Beavis A; Lopez-Botet M; Ebert EC; Winchester RJ
Immunity; 2002 Oct; 17(4):487-99. PubMed ID: 12387742
[TBL] [Abstract][Full Text] [Related]
43. Porcine T lymphocytes and NK cells--an update.
Gerner W; Käser T; Saalmüller A
Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
[TBL] [Abstract][Full Text] [Related]
44. Human tumor-derived exosomes down-modulate NKG2D expression.
Clayton A; Mitchell JP; Court J; Linnane S; Mason MD; Tabi Z
J Immunol; 2008 Jun; 180(11):7249-58. PubMed ID: 18490724
[TBL] [Abstract][Full Text] [Related]
45. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.
Maniar A; Zhang X; Lin W; Gastman BR; Pauza CD; Strome SE; Chapoval AI
Blood; 2010 Sep; 116(10):1726-33. PubMed ID: 20519625
[TBL] [Abstract][Full Text] [Related]
46. Aberrant expression of NK cell receptors in Epstein-Barr virus-positive gammadelta T-cell lymphoproliferative disorders.
Zhang Y; Ohyashiki JH; Shimizu N; Ohyashiki K
Hematology; 2010 Feb; 15(1):43-7. PubMed ID: 20132662
[TBL] [Abstract][Full Text] [Related]
47. NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
Borrego F; Kabat J; Sanni TB; Coligan JE
J Immunol; 2002 Dec; 169(11):6102-11. PubMed ID: 12444112
[TBL] [Abstract][Full Text] [Related]
48. Transendothelial migratory pathways of V delta 1+TCR gamma delta+ and V delta 2+TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients: involvement of phosphatidylinositol 3 kinase and calcium calmodulin-dependent kinase II.
Poggi A; Zocchi MR; Carosio R; Ferrero E; Angelini DF; Galgani S; Caramia MD; Bernardi G; Borsellino G; Battistini L
J Immunol; 2002 Jun; 168(12):6071-7. PubMed ID: 12055216
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of CD94/NKG2A inhibitory receptor on decreased γδ T cells in patients with systemic lupus erythematosus.
Wang L; Kang N; Zhou J; Guo Y; Zhang X; Cui L; Ba D; He W
Scand J Immunol; 2012 Jul; 76(1):62-9. PubMed ID: 22486170
[TBL] [Abstract][Full Text] [Related]
50. Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.
Correia DV; d'Orey F; Cardoso BA; Lança T; Grosso AR; deBarros A; Martins LR; Barata JT; Silva-Santos B
PLoS One; 2009 May; 4(5):e5657. PubMed ID: 19479075
[TBL] [Abstract][Full Text] [Related]
51. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Derkow K; Krüger C; Dembny P; Lehnardt S
PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
[TBL] [Abstract][Full Text] [Related]
52. Germ-line and rearranged Tcrd transcription distinguish bona fide NK cells and NK-like gammadelta T cells.
Stewart CA; Walzer T; Robbins SH; Malissen B; Vivier E; Prinz I
Eur J Immunol; 2007 Jun; 37(6):1442-52. PubMed ID: 17492716
[TBL] [Abstract][Full Text] [Related]
53. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.
Van Beneden K; Stevenaert F; De Creus A; Debacker V; De Boever J; Plum J; Leclercq G
J Immunol; 2001 Apr; 166(7):4302-11. PubMed ID: 11254682
[TBL] [Abstract][Full Text] [Related]
54. Skewed inhibitory receptors expression in a TAP2-deficient patient.
Crespí C; Rosa Julià M; Muñoz-Saa I; Pérez-Castellano MT; Milà J; Matamoros N
Immunol Lett; 2003 Apr; 86(2):149-53. PubMed ID: 12644316
[TBL] [Abstract][Full Text] [Related]
55. Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytes.
Decaup E; Duault C; Bezombes C; Poupot M; Savina A; Olive D; Fournié JJ
Immunol Lett; 2014 Sep; 161(1):133-7. PubMed ID: 24925024
[TBL] [Abstract][Full Text] [Related]
56. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.
Borrego F; Robertson MJ; Ritz J; Peña J; Solana R
Immunology; 1999 May; 97(1):159-65. PubMed ID: 10447727
[TBL] [Abstract][Full Text] [Related]
57. Distinct pattern of human Vdelta1 gammadelta T cells recognizing MICA.
Li J; Cui L; He W
Cell Mol Immunol; 2005 Aug; 2(4):253-8. PubMed ID: 16274622
[TBL] [Abstract][Full Text] [Related]
58. Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate.
Kato Y; Tanaka Y; Tanaka H; Yamashita S; Minato N
J Immunol; 2003 Apr; 170(7):3608-13. PubMed ID: 12646624
[TBL] [Abstract][Full Text] [Related]
59. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
Bouet-Toussaint F; Cabillic F; Toutirais O; Le Gallo M; Thomas de la Pintière C; Daniel P; Genetet N; Meunier B; Dupont-Bierre E; Boudjema K; Catros V
Cancer Immunol Immunother; 2008 Apr; 57(4):531-9. PubMed ID: 17764010
[TBL] [Abstract][Full Text] [Related]
60. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.
Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y
Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
